ABOUT: NeuroMetrix (NURO) announced that it expects to meet its planned launch date for its latest product, NC-statDPNCheck, which is a fast, accurate, and quantitative test for the evaluation of systemic neuropathies such as diabetic peripheral neuropathy—The marketing launch will occur during the exhibition at the American Diabetes Association 71st Scientific Sessions in San Diego, CA on June 24 through the 28, 2011–NeuroMetrix is a science-based health care company improving patient care through neurotechnology— The company develops and markets innovative products for the detection, diagnosis, and monitoring of peripheral nerve disorders such as those associated with diabetes and carpal tunnel syndrome